Elcriton, Inc. is a biotechnology, cleantech company located in Newark, DE, USA that evolved out of the academic laboratory of Professor Terry Papoutsakis with the assistance of Dr. Bryan P. Tracy. Our company’s mission is to create novel, biochemical technologies to immediately address the renewable energy needs of the United States, and to shape the sustainable chemical markets of tomorrow.
Professor Terry E. Papoutsakis, Ph.D.
Founder & President
Prof. Papoutsakis is the Eugene DuPont Chaired Professor of Chemical Engineering at the University of Delaware. He started his career at Rice University and then moved to Northwestern University where he served on the faculty for 20 years, serving as a Walter P. Murphy Chaired Professor. Terry has over 25 years of experience in microbial biotechnologies, management experience for numerous federal and non-federal grants, authorship on over 220 scientific publications and 20 years of consulting experience. Terry also served on the Scientific Advisory Boards of several companies and co-founded Tissue Therapeutics that was later sold to Resodyn Corporation.
Terry has received numerous international honors and awards, including the 2010 International Metabolic Engineering Award, the 2010 Gaden Award, the 2005 Amgen Biochemical Engineering Award, the 2004 Merck Cell-Culture Engineering Award, the 2003 Alpha Chi Sigma Award of the American Institute of Chemical Engineers, the 1995 AIChE Bioengineering Division Award, the 1998 ACS BIOT Marvin Johnson Award, and the Presidential Young Investigator Award for NSF (1985-90). He is a Founding Fellow of the American Institute of Medical and Biological Engineers (AIMBE). He is an elected Fellow of the American Association for the Advancement Of Science (1998) and the American Academy of Microbiology (2005). Terry received a diploma in Chemical Engineering (1974) from the National Technical University of Athens and both a M.S. (1977) and Ph.D. (1980) in Chemical Engineering from Purdue University.
Bryan P. Tracy, Ph.D
CEO & Lead Scientist
Dr. Tracy has served a lead role in raising over $1.3 million in Small Business Innovation Research (SBIR) Grant seed funding through multiple federal agencies. In addition to serving as Principal Investigator on all of Elcriton’s SBIRs, Bryan manages the tasks towards commercializing our improved microbial catalysts and superior genetic engineering technologies. Bryan has nearly 10 years of experience in microbial engineering and bioprocess development research in both academic and industrial settings. He is also a primary inventor on seven patent applications, an author on many scientific publications, a Supplemental Faculty member at the University of Delaware (Department of Chemical Engineering), and an industrial liaison to the Temple University, Fox School of Business - Enterprise Management Consulting Practice. Most recently, Bryan was honored with acceptance into the 2012 class of fellows for Leadership Delaware.
During his Ph.D. studies, Bryan was a Cabell Fellow and NIH Predoctoral Biotechnology Training Fellow. During his undergraduate studies, he worked in the Optimization Department at Novozymes N/A where he assisted in developing a novel biomass separation process for fungal hosts. Bryan received his B.S. in Chemical Engineering (2004) from North Carolina State University and a Ph.D. in Chemical and Biological Engineering (2009) from Northwestern University.